Vanguard Group Inc T Rx Ade Health, Inc Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.29 - $0.53 $34,542 - $63,129	-119,112 Reduced 75.04%	39,629 $11,000
Q4 2022 Feb 10, 2023	SELL	$0.29 - $17.39 $5,953 - $357,016	-20,530 Reduced 11.45%	158,741 $63,000
Q3 2022 Nov 14, 2022	BUY	$1.06 - $16.94 $9,249 - $147,818	8,726 Added 5.12%	179,271 $203,000
Q2 2022 Aug 12, 2022	SELL	$1.24 - $2.47 $243 - $484	-196 Reduced 0.11%	170,545 $277,000
Q3 2021 Nov 12, 2021	BUY	$4.66 - $7.17 $149,632 - $230,228	32,110 Added 23.16%	170,741 $841,000
Q2 2021 Aug 13, 2021	BUY	$3.11 - $6.67 $431,142 - $924,668	138,631 New	138,631 $613,000

Ticker MEDS
Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Shares Outstandng 9,318,710
Market Cap $68.5M
Description
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 m...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.